Search
for
Sort by
Research 61–90 of 130
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Efficacy of Dupilumab in Patients with Atopic Dermatitis and Alopecia Areata: A Case Series
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
- Systemic treatments for alopecia areata: A systematic review
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- New therapies for alopecia areata
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Baricitinib regrows hair in adolescents with alopecia areata